Curiox Biosystems큐리옥스바이오시스템즈
445680 · KOSDAQ · ₩445680 · 큐리옥스바이오시스템즈
₩62,400▲ ₩100 (0.16%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | ₩5.2B | ₩4.6B | ₩6.8B |
| Cost of sales | ₩3B | ₩2B | ₩3B |
| Gross profit | ₩2.1B | ₩2.6B | ₩3.8B |
| Operating income | −₩12B | −₩13B | −₩11B |
| Net income | −₩27B | −₩8.1B | −₩10B |
| Net income to shareholders | −₩27B | −₩8.1B | −₩10B |
Balance sheet
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total assets | ₩78B | ₩71B | ₩58B |
| Current assets | ₩40B | ₩32B | ₩22B |
| Cash and equivalents | ₩15B | ₩24B | ₩18B |
| Total liabilities | ₩25B | ₩22B | ₩4.9B |
| Current liabilities | ₩23B | ₩20B | ₩2.7B |
| Borrowings | ₩1.8B | ₩7.4B | — |
| Total equity | ₩53B | ₩49B | ₩53B |
| Shareholders' equity | ₩53B | ₩49B | ₩53B |
Cash flow
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Cash from operations | −₩11B | −₩9.7B | −₩8.2B |
| Capital spending | ₩136M | ₩258M | ₩212M |
| Free cash flow | −₩11B | −₩10B | −₩8.4B |
Consolidated where available. Amounts in won.
Also known as: Curiox Biosystems / 큐리옥스바이오시스템즈 / 445680 / KRX:445680
Source: KRX statistical information